Suzlon Energy Gets Nuvama Upgrade After Q3 Earnings, Valuation Comfort — Stock Target Sees 19% Upside
Suzlon Energy Ltd. received a rating upgrade from 'hold' to 'buy' on its stock from Nuvama after strong third quarter earnings, order book and valuation comfort due to recent price correction.
The brokerage has set a target of Rs 60 for Suzlon Energy share price, implying a potential upside of 19% over the previous close. The target price is 35 times the fiscal 2027 earnings projection.
Nuvama has maintained a long-term positive outlook on the company and adjusted the earnings estimates over three years to reflect improved execution in the current fiscal from 1.44 GW to 1.5 GW, the Renom acquisition, and other factors.
The brokerage noted that the December quarter saw robust execution of 447 MW compared to estimate of 360 MW, resulting in a top line of nearly Rs 3,000 crore. The execution uptick is aided by capacity ramp up to 4.5 GW.
Operating margin improved due to higher wind turbine generator mix-led operating leverage, resulting in beat to forecast despite elevated depreciation and interest costs in the wake of Renom acquisition.
The 5.5 GW order book, which marks a 3.4 times jump from 2.29 GW in December 2023, is executable over 24 months, Nuvama said.
Suzlon Energy share price has corrected 40% since its life high in mid-September last year.
The wind turbine maker's consolidated net profit jumped 90% on an annual basis in the third quarter of the current financial year, beating analysts' estimates.
The company posted a profit of Rs 386 crore in the third quarter, according to an exchange filing on Tuesday. Analysts polled by Bloomberg had estimated a profit of Rs 350 crore.
Revenue surged 91% to Rs 2,968.8 crore, beating estimate of Rs 2,855 crore.
Shares of Suzlon Energy closed flat on Tuesday, ahead of the results.
Five out of the six analysts tracking Suzlon Energy have a 'buy' rating on the stock, one recommend a 'hold', according to Bloomberg data. The average of 12-month analyst price target of Rs 75.17 implies a potential upside of nearly 50%.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
